References
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease NHLBI/WHO Workshop Report. Rev. ed. 2003, 〈http://www.goldcopd.com〉. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Accession: 8/3/04.
- Lamb D, Reid L. Goblet cell increase in rat bronchial epithelium after exposure to cigarette and cigar tobacco smoke.Br Med J 1969; 1(635):33–35. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K, King M. Mucus physiology and pathophysiology: therapeutic aspects. In: Derenne J P, Similowski T, Whitelaw W A, eds. Chronic Obstructive Lung Disease. New York: Marcel Dekker, 1996:391–411.
- Aikawa T, Shimura S, Sasaki H, Takishima T, Yaegashi H, Takahashi T. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease.Am Rev Respir Dis 1989; 140(2):477–482. [PUBMED], [INFOTRIEVE], [CSA]
- Vastag E, Matthys H, Zsamboki G, Kohler D, Daikeler G. Mucociliary clearance in smokers.Eur J Respir Dis 1986; 68(2):107–113. [PUBMED], [INFOTRIEVE], [CSA]
- Bridges R B, Wyatt R J, Rehm S R. Effects of smoking on inflammatory mediators and their relationship to pulmonary dysfunction.Eur J Respir Dis, Suppl 1986; 146:145–152. [CSA]
- Dalhamn T. In vivo and in vitro ciliotoxic effects of tobacco smoke.Arch Environ Health 1970; 21(5):633–634. [PUBMED], [INFOTRIEVE], [CSA]
- King M, Rubin B K. Rheology of airway mucus: relationship with clearance function. In: Takishima T, Shimura S, eds. Airway Secretion: Physiological Bases for the Control of Mucous Hypersecretion. New York: Marcel Dekker, 1994:283–314.
- Rubin B K, King M. The physiologic effects of smoking in COPD.J Respir Dis 1993; 14:19–25. [CSA]
- Zayas J G, Rubin B K, Ramirez O, York E, Lien D, King M. Bronchial mucus rheology and clearability in lung cancer.J Natl Inst Respir Dis 1993; 6:12–20. [CSA]
- Jamal K, Cooney T P, Fleetham J A, Thurlbeck W M. Chronic bronchitis. Correlation of morphologic findings to sputum production and flow rates.Am Rev Respir Dis 1984; 129(5):719–722. [PUBMED], [INFOTRIEVE], [CSA]
- Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.Thorax 1990; 45(8):579–585. [PUBMED], [INFOTRIEVE], [CSA]
- In: Rubin B K, Tamaoki J, eds. Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. BaselSwitzerland: Birkhaeuser Verlag, 2004.
- King M, El Azab J, Phillips D M, Angus G E. Antigen challenge and canine tracheal mucus.Int Arch Allergy Appl Immunol 1985; 77(3):337–342. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K, Ramirez O, Zayas J G, Finegan B, King M. Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action.Am Rev Respir Dis 1992; 145(3):545–547. [PUBMED], [INFOTRIEVE], [CSA]
- Dirksen H, Hermansen F, Groth S, Molgaard F. Mucociliary clearance in early simple chronic bronchitis.Eur J Respir Dis, Suppl 1987; 153:145–149. [CSA]
- Matthys H, Vastag E, Kohler D, Daikeler G, Fischer J. Mucociliary clearance in patients with chronic bronchitis and bronchial carcinoma.Respiration 1983; 44(5):329–337. [PUBMED], [INFOTRIEVE], [CSA]
- Drost E M, Skwarski K M, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD.Thorax 2005; 60(4):293–300. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- MacNee W. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.Novartis Found Symp 2001; 234:169–185. [PUBMED], [INFOTRIEVE], [CSA]
- Lopez-Vidriero M T. Airway mucus; production and composition.Chest 1981; 80(6 suppl):799–804. [PUBMED], [INFOTRIEVE], [CSA]
- Puchelle E, Zahm J M, Girard F, Bertrand A, Polu J M, Aug F, Sadoul P. Mucociliary transport in vivo and in vitro. Relations to sputum properties in chronic bronchitis.Eur J Respir Dis 1980; 61(5):254–264. [PUBMED], [INFOTRIEVE], [CSA]
- Jeffery P K. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease.Am Rev Respir Dis 1991; 143(5 Pt 1):1152–1158. [PUBMED], [INFOTRIEVE], [CSA]
- Schoonbrood D F, Lutter R, Habets F J, Roos C M, Jansen H M, Out T A. Analysis of plasma-protein leakage and local secretion in sputum from patients with asthma and chronic obstructive pulmonary disease.Am J Respir Crit Care Med 1994; 150(6 Pt 1):1519–1527. [PUBMED], [INFOTRIEVE], [CSA]
- Zayas J G, Man G C, King M. Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer.Am Rev Respir Dis 1990; 141(5 Pt 1):1107–1113. [PUBMED], [INFOTRIEVE], [CSA]
- Boat T F, Cheng P W. Biochemistry of airway mucus secretions.Fed Proc 1980; 39:3067–3074. [PUBMED], [INFOTRIEVE], [CSA]
- Kaliner M, Marom Z, Patow C, Shelhamer J. Human respiratory mucus.J Allergy Clin Immunol 1984; 73(3):318–323. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaliner M, Shelhamer J H, Borson B, Nadel J, Patow C, Marom Z. Human respiratory mucus.Am Rev Respir Dis 1986; 134(3):612–621. [PUBMED], [INFOTRIEVE], [CSA]
- Thornton D J, Sheehan J K, Lindgren H, Carlstedt I. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural ‘architecture’.Biochem J 1991; 276(Pt 3):667–675. [PUBMED], [INFOTRIEVE], [CSA]
- Sheehan J K, Richardson P S, Fung D C, Howard M, Thornton D J. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus.Am J Respir Cell Mol Biol 1995; 13(6):748–756. [PUBMED], [INFOTRIEVE], [CSA]
- Davies J R, Hovenberg H W, Linden C J, Howard R, Richardson P S, Sheehan J K, Carlstedt I. Mucins in airway secretions from healthy and chronic bronchitic subjects.Biochem J 1996; 313(Pt 2):431–439. [PUBMED], [INFOTRIEVE], [CSA]
- Reid C J, Gould S, Harris A. Developmental expression of mucin genes in the human respiratory tract.Am J Respir Cell Mol Biol 1997; 17(5):592–598. [PUBMED], [INFOTRIEVE], [CSA]
- Davies J R, Herrmann A, Russell W, Svitacheva N, Wickstrom C, Carlstedt I. Respiratory tract mucins: structure and expression patterns.Novartis Found Symp 2002; 248:76–88. [PUBMED], [INFOTRIEVE], [CSA]
- Rose M C, Nickola T J, Voynow J A. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia.Am J Respir Cell Mol Biol 2001; 25(5):533–537. [PUBMED], [INFOTRIEVE], [CSA]
- Kirkham S, Sheehan J K, Knight D, Richardson P S, Thornton D J. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.Biochem J 2002; 361(Pt 3):537–546. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wickstrom C, Davies J R, Eriksen G V, Veerman E C, Carlstedt I. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.Biochem J 1998; 334(Pt 3):685–693. [PUBMED], [INFOTRIEVE], [CSA]
- Thornton D J, Carlstedt I, Howard M, Devine P L, Price M R, Sheehan J K. Respiratory mucins: identification of core proteins and glycoforms.Biochem J 1996; 316(Pt 3):967–975. [PUBMED], [INFOTRIEVE], [CSA]
- Melton L. Does mucus hypersecretion matter in airway disease?Lancet 2002; 359(9321):1924, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.Am J Respir Crit Care Med 1996; 153(5):1530–1535. [PUBMED], [INFOTRIEVE], [CSA]
- Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack.Chest 1992; 101(4):916–921. [PUBMED], [INFOTRIEVE], [CSA]
- Welsh M J, Ramsey B W, Accurso F J, Cutting G R. Cystic fibrosis. In: Scriver C R, Beaudet A L, Sly W S, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:5121–5188.
- Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O. The nature of small-airway obstruction in chronic obstructive pulmonary disease.N Engl J Med 2004; 350(26):2645–2653. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takeyama K, Dabbagh K, Lee H M, Agusti C, Lausier J A, Ueki I F, Grattan K M, Nadel J A. Epidermal growth factor system regulates mucin production in airways.Proc Natl Acad Sci U S A 1999; 96(6):3081–3086. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection.Eur Respir J 1995; 8(8):1333–1338. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Voelkel N F, Tuder R. COPD: exacerbation.Chest 2000; 117(5 suppl 2):376S–379S. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sheehan J K, Howard M, Richardson P S, Longwill T, Thornton D J. Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug.Biochem J 1999; 338(Pt 2):507–513. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Voynow J A, Selby D M, Rose M C. Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals.Lung 1998; 176:345–354. [PUBMED], [INFOTRIEVE], [CSA]
- Thornton D J, Davies J R, Kraayenbrink M, Richardson P S, Sheehan J K, Carlstedt I. Mucus glycoproteins from ‘normal’ human tracheobronchial secretion.Biochem J 1990; 265(1):179–186. [PUBMED], [INFOTRIEVE], [CSA]
- Hovenberg H W, Davies J R, Carlstedt I. Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells.Biochem J 1996; 318(Pt 1):319–324. [PUBMED], [INFOTRIEVE], [CSA]
- Sheehan J K, Hanski C, Corfield A P, Paraskeva C, Thornton D J. Mucin biosynthesis and macromolecular assembly.Biochem Soc Trans 1995; 23(4):819–821. [PUBMED], [INFOTRIEVE], [CSA]
- Sheehan J K, Kirkham S, Howard M, Woodman P, Kutay S, Brazeau C, Buckley J, Thornton D J. Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin.J Biol Chem 2004; 279(15):15698–15705. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Innes A L, Dolganov G M, Woodruff P G, Cadbury P, Carter R, Ferrando R, Lazarus S C, Fahy J V. Characterizing epithelial mucin stores and mucin gene expression in COPD.Am J Respir Crit Care Med 2004; 169(7):A712, [CSA]
- Caramori G, Di Gregorio C, Carlstedt I, Casolari P, Guzzinati I, Adcock I M, Barnes P J, Ciaccia A, Cavallesco G, Chung K F, Papi A. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.Histopathology 2004; 45(5):477–484. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Albers G M, Tomkiewicz R P, May M K, Ramirez O E, Rubin B K. Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability.J Appl Physiol 1996; 81(6):2690–2695. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K. Surface properties of respiratory secretions: relationship to mucus transport. In: Baum G, Priel Z, Roth Y, Liron N, Ostfield E, eds. Cilia, Mucus, and Mucociliary Interactions. New York: Marcel Dekker, 1998:317–323.
- Picot R, Das I, Reid L. Pus, deoxyribonucleic acid, and sputum viscosity.Thorax 1978; 33(2):235–242. [PUBMED], [INFOTRIEVE], [CSA]
- Verdugo P, Tam P Y, Butler J. Conformational structure of respiratory mucus studied by laser correlation spectroscopy.Biorheology 1983; 20(2):223–230. [PUBMED], [INFOTRIEVE], [CSA]
- Sheils C A, Kas J, Travassos W, Allen P G, Janmey P A, Wohl M E, Stossel T P. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease.Am J Pathol 1996; 148(3):919–927. [PUBMED], [INFOTRIEVE], [CSA]
- Tomkiewicz R P, Kishioka C, Freemann J, Rubin B K. DNA and actin filaments ultrastructure in cystic fibrosis sputum. In: Baum G L, Priel Z, Roth Y, Liron N, Ostfield E, eds. Cilia, Mucus, and Mucociliary Interactions. New York: Marcel Dekker, 1998:333–341.
- Ferry J D. Viscoelastic Properties of Polymers. 3rd ed. New York: Wiley, 1980.
- Shak S, Capon D J, Hellmiss R, Marsters S A, Baker C L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.PNAS 1990; 87(23):9188–9192. [PUBMED], [INFOTRIEVE], [CSA]
- Shah P L, Conway S, Scott S F, Rainisio M, Wildman M, Stableforth D, Hodson M E. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.Respiration 2001; 68(2):160–164. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shah P L, Scott S F, Knight R A, Marriott C, Ranasinha C, Hodson M E. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.Thorax 1996; 51(2):119–125. [PUBMED], [INFOTRIEVE], [CSA]
- Zahm J M, Galabert C, Chaffin A, Chazalette J P, Grosskopf C, Puchelle E. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile.Am J Respir Crit Care Med 1998; 157(6 Pt 1):1779–1784. [PUBMED], [INFOTRIEVE], [CSA]
- Fick R B, Anzueto A, Mahutte K. Recombinant DNase mortality reduction in acute exacerbations of chronic bronchitis.Clin Res 1994; 42(2):A294, [CSA]
- Bone R C, Fuchs H, Fox N L. The chronic obstructive pulmonary disease mortality endpoint trial.Chest 1995; 108(3 suppl):R, [CSA]
- Wills P J, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole P J. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.Am J Respir Crit Care Med 1996; 154(2 Pt 1):413–417. [PUBMED], [INFOTRIEVE], [CSA]
- Jager E G. Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients.Clin Ther 1989; 11(3):341–362. [PUBMED], [INFOTRIEVE], [CSA]
- Thomson M L, Pavia D, McNicol M W. A preliminary study of the effect of guaiphenesin on mucociliary clearance from the human lung.Thorax 1973; 28(6):742–747. [PUBMED], [INFOTRIEVE], [CSA]
- Shim C, King M, Williams M H Jr. Lack of effect of hydration on sputum production in chronic bronchitis.Chest 1987; 92(4):679–682. [PUBMED], [INFOTRIEVE], [CSA]
- Pavia D, Agnew J E, Glassman J M, Sutton P P, Lopez-Vidriero M T, Soyka J P, Clarke S W. Effects of iodopropylidene glycerol on tracheobronchial clearance in stable, chronic bronchitic patients.Eur J Respir Dis 1985; 67(3):177–184. [PUBMED], [INFOTRIEVE], [CSA]
- Petty T L. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis.Chest 1990; 97(1):75–83. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K, Ramirez O, Ohar J A. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis.Chest 1996; 109(2):348–352. [PUBMED], [INFOTRIEVE], [CSA]
- Pavia D, Thomson M L, Clarke S W. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol.Am Rev Respir Dis 1978; 117(2):199–203. [PUBMED], [INFOTRIEVE], [CSA]
- Rutgers S R, Timens W, Kaufmann H F, van der Mark T W, Koeter G H, Postma D S. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.Eur Respir J 2000; 15(1):109–115. [PUBMED], [INFOTRIEVE], [CSA]
- Eng P A, Morton J, Douglass J A, Riedler J, Wilson J, Robertson C F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.Pediatr Pulmonol 1996; 21(2):77–83. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Poole P J, Brodie S M, Stewart J M, Black P N. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).Aust N Z J Med 1998; 28(3):322–326. [PUBMED], [INFOTRIEVE], [CSA]
- Smith J J, Travis S M, Greenberg E P, Welsh M J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid [published erratum appears in Cell 1996 Oct. 18;87(2):following 355].Cell 1996; 85:229–236. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Taube C, Holz O, Mucke M, Jorres R A, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease.Am J Respir Crit Care Med 2001; 164(10 Pt 1):1810–1815. [PUBMED], [INFOTRIEVE], [CSA]
- King M, Dasgupta B, Tomkiewicz R P, Brown N E. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.Am J Respir Crit Care Med 1997; 156(1):173–177. [PUBMED], [INFOTRIEVE], [CSA]
- Zuhlke I E, Kanniess F, Richter K, Nielsen-Gode D, Bohme S, Jorres R A, Magnussen H. Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.Eur Respir J 2003; 22(6):926–930. [PUBMED], [INFOTRIEVE], [CSA]
- Sheffner A L, Medler E M, Jacobs L W, Sarett H P. The in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine.Am Rev Respir Dis 1964; 90:721–729. [PUBMED], [INFOTRIEVE], [CSA]
- Rhee C S, Majima Y, Cho J S, Arima S, Min Y G, Sakakura Y. Effects of mucokinetic drugs on rheological properties of reconstituted human nasal mucus.Arch Otolaryngol Head Neck Surg 1999; 125(1):101–105. [PUBMED], [INFOTRIEVE], [CSA]
- Boman G, Backer U, Larsson S, Melander B, Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.Eur J Respir Dis 1983; 64(6):405–415. [PUBMED], [INFOTRIEVE], [CSA]
- Brocard H, Charpin J, Germouty J. Multicenter, double-blind study of oral acetylcysteine vs. placebo.Eur J Respir Dis, Suppl 1980; 111:65–69. [CSA]
- Dorow P, Weiss T, Felix R, Kohler M. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.Arzneim-Forsch 1986; 36(1):131–133. [CSA]
- Dueholm M, Nielsen C, Thorshauge H, Evald T, Hansen N C, Madsen H D, Maltbaek N. N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study.Respir Med 1992; 86(2):89–92. [PUBMED], [INFOTRIEVE], [CSA]
- Grassi C, Morandini G C. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis.Eur J Clin Pharmacol 1976; 09(5–6):393–396. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hansen N C, Skriver A, Brorsen-Riis L, Balslov S, Evald T, Maltbaek N, Gunnersen G, Garsdal P, Sander P, Pedersen J Z. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis.Respir Med 1994; 88(7):531–535. [PUBMED], [INFOTRIEVE], [CSA]
- Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.Thorax 1985; 40(11):832–835. [CSA]
- Tattersall A B, Bridgman K M, Huitson A. Irish general practice study of acetylcysteine (Fabrol) in chronic bronchitis.J Int Med Res 1984; 12(2):96–101. [PUBMED], [INFOTRIEVE], [CSA]
- Gerrits C M, Herings R M, Leufkens H G, Lammers J W. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.Eur Respir J 2003; 21(5):795–798. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Black P N, Morgan-Day A, McMillan T E, Poole P J, Young R P. Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease.BMC Pulm Med 2004; 4(1):13, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Christensen F, Kjer J, Ryskjaer S, Arseth-Hansen P. Bromhexine in chronic bronchitis.Br Med J 1970; 4(727):117, [PUBMED], [INFOTRIEVE], [CSA]
- Clarke S W, Lopez-Vidriero M T, Pavia D, Thomson M L. The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.Br J Clin Pharmacol 1979; 7(1):39–44. [PUBMED], [INFOTRIEVE], [CSA]
- Pavia D, Sutton P P, Lopez-Vidriero M T, Agnew J E, Clarke S W. Drug effects on mucociliary function.Eur J Respir Dis, Suppl 1983; 128(Pt 1):304–317. [CSA]
- Gent M, Knowlson P A, Rime F J. Effect of bromhexine on ventilatory capacity in patients with a variety of chest diseases.Lancet 1969; 2(7630):1094–1096. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Braga P C, Allegra L, Rampoldi C, Ornaghi A, Beghi G. Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis.Respiration 1990; 57(6):353–358. [PUBMED], [INFOTRIEVE], [CSA]
- Castiglioni C L, Gramolini C. Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis.Respiration 1986; 50(3):202–217. [PUBMED], [INFOTRIEVE], [CSA]
- Goodman R M, Yergin B M, Sackner M A. Effects of S-carboxymethylcysteine on tracheal mucus velocity.Chest 1978; 74(6):615–618. [PUBMED], [INFOTRIEVE], [CSA]
- Sueyoshi S, Miyata Y, Masumoto Y, Ishibashi Y, Matsuzawa S, Harano N, Tsuru K, Imai S. Reduced airway inflammation and remodeling in parallel with mucin 5AC protein expression decreased by s-carboxymethylcysteine, a mucoregulant, in the airways of rats exposed to sulfur dioxide.Int Arch Allergy Immunol 2004; 134(4):273–280. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schreiber J, Bohnsteen B, Rosahl W. Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.Eur J Med Res 2002; 7(3):98–102. [PUBMED], [INFOTRIEVE], [CSA]
- Tekeres M, Horvath A, Bardosi L, Kenyeres P. Clinical studies on the mucolytic effect of mesna.Clin Ther 1981; 4(1):56–60. [PUBMED], [INFOTRIEVE], [CSA]
- Ramsey B W, Astley S J, Aitken M L, Burke W, Colin A A, Dorkin H L, Eisenberg J D, Gibson R L, Harwood I R, Schidlow D V. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.Am Rev Respir Dis 1993; 148(1):145–151. [PUBMED], [INFOTRIEVE], [CSA]
- Hubbard R C, McElvaney N G, Birrer P, Shak S, Robinson W W, Jolley C, Wu M, Chernick M S, Crystal R G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.N Engl J Med 1992; 326(12):812–815. [PUBMED], [INFOTRIEVE], [CSA]
- Fuchs H J, Borowitz D S, Christiansen D H, Morris E M, Nash M L, Ramsey B W, Rosenstein B J, Smith A L, Wohl M E. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group [see comments].N Engl J Med 1994; 331:637–642. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Doring G, van Koningsbruggen S, Wahn U, Ratjen F, Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.Am J Respir Crit Care Med 2004; 169(6):719–725. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Puchelle E, Zahm J M, de Bentzmann S, Grosskopf C, Shak S, Mougel D, Polu J M. Effects of rhDNase on purulent airway secretions in chronic bronchitis.Eur Respir J 1996; 9(4):765–769. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vasconcellos C A, Allen P G, Wohl M E, Drazen J M, Janmey P A, Stossel T P. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin.Science 1994; 263(5149):969–971. [PUBMED], [INFOTRIEVE], [CSA]
- Fuloria M, Rubin B K. Evaluating the efficacy of mucoactive aerosol therapy.Respir Care 2000; 45(7):868–873. [PUBMED], [INFOTRIEVE], [CSA]
- Mossberg B, Strandberg K, Philipson K, Camner P. Tracheobronchial clearance in bronchial asthma: response to beta-adrenoceptor stimulation.Scand J Respir Dis 1976; 57(3):119–128. [PUBMED], [INFOTRIEVE], [CSA]
- Isawa T, Teshima T, Hirano T, Ebina A, Konno K. Effect of oral salbutamol on mucociliary clearance mechanisms in the lungs.Tohoku J Exp Med 1986; 150(1):51–61. [PUBMED], [INFOTRIEVE], [CSA]
- Pavia D, Bateman J R, Sheahan N F, Clarke S W. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.Eur J Respir Dis 1980; 61(5):245–253. [PUBMED], [INFOTRIEVE], [CSA]
- Mortensen J, Groth S, Lange P, Hermansen F. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.Thorax 1991; 46(11):817–823. [PUBMED], [INFOTRIEVE], [CSA]
- Wanner A. Effects of methylxanthines on airway mucociliary function.Am J Med 1985; 79(6A):16–21. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Finley T N, Ladman A J. Low yield of pulmonary surfactant in cigarette smokers.N Engl J Med 1972; 286(5):223–227. [PUBMED], [INFOTRIEVE], [CSA]
- Higenbottam T. Pulmonary surfactant and chronic lung disease.Eur J Respir Dis, Suppl 1987; 153:222–228. [CSA]
- Girod S, Galabert C, Lecuire A, Zahm J M, Puchelle E. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.Pediatr Pulmonol 1992; 13(1):22–27. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K. Therapeutic aerosols and airway secretions.J Aerosol Med 1996; 9(1):123–130. [PUBMED], [INFOTRIEVE], [CSA]
- Anzueto A, Jubran A, Ohar J A, Piquette C A, Rennard S I, Colice G, Pattishall E N, Barrett J, Engle M, Perret K A, Rubin B K. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.JAMA 1997; 278(17):1426–1431. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yanaura S, Takeda H, Nishimura T, Misawa M. Histological and histochemical changes of tracheal secretory cells following bromhexine treatment (author's transl).Nippon Yakurigaku Zasshi 1981; 77(6):559–568. [PUBMED], [INFOTRIEVE], [CSA]
- Ziment I. Mucokinetic Agents. Respiratory Pharmacology and Therapeutics. Philadelphia: W.B. Saunders Company, 1976:60–104.
- Valenti S, Marenco G. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial.Respiration 1989; 56(1–2):11–15. [PUBMED], [INFOTRIEVE], [CSA]
- Germouty J, Jirou-Najou J L. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.Respiration 1987; 51 suppl 1:37–41. [PUBMED], [INFOTRIEVE], [CSA]
- Ericsson C H, Juhasz J, Mossberg B, Philipson K, Svartengren M, Camner P. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.Eur J Respir Dis 1987; 70(3):163–170. [PUBMED], [INFOTRIEVE], [CSA]
- Olivieri D, Zavattini G, Tomasini G, Daniotti S, Bonsignore G, Ferrara G, Carnimeo N, Chianese R, Catena E, Marcatili S. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo.Respiration 1987; 51 suppl 1:42–51. [PUBMED], [INFOTRIEVE], [CSA]
- Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, long-term, multicenter study in 5,635 patients.Respiration 1989; 55 suppl 1:84–96. [CSA]
- Guyatt G H, Townsend M, Kazim F, Newhouse M T. A controlled trial of ambroxol in chronic bronchitis.Chest 1987; 92(4):618–620. [PUBMED], [INFOTRIEVE], [CSA]
- Rogers D F. Pharmacological regulation of the neuronal control of airway mucus secretion.Curr Opin Pharmacol 2002; 2(3):249–255. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ramnarine S I, Haddad E B, Khawaja A M, Mak J C, Rogers D F. On muscarinic control of neurogenic mucus secretion in ferret trachea.J Physiol 1996; 494(Pt 2):577–586. [PUBMED], [INFOTRIEVE], [CSA]
- Nakaya M, Yuasa T, Usui N. Immunohistochemical localization of subtypes of muscarinic receptors in human inferior turbinate mucosa.Ann Otol Rhinol Laryngol 2002; 111(7 Pt 1):593–597. [PUBMED], [INFOTRIEVE], [CSA]
- Hybbinette J C, Mercke U. Effects of sympathomimetic agonists and antagonists on mucociliary activity.Acta Oto-Laryngol 1982; 94(1–2):121–130. [CSA]
- Francis R A, Thompson M L, Pavia D, Douglas R B. Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects.Br J Dis Chest 1977; 71(3):173–178. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Matthys H, Hundenborn J, Daikeler G, Kohler D. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis.Respiration 1985; 48(4):329–339. [PUBMED], [INFOTRIEVE], [CSA]
- Lopez-Vidriero M T, Costello J, Clark T J, Das I, Keal E E, Reid L. Effect of atropine on sputum production.Thorax 1975; 30(5):543–547. [PUBMED], [INFOTRIEVE], [CSA]
- Giordano A, Holsclaw D, Litt M. Effects of various drugs on canine tracheal mucociliary transport.Ann Otol Rhinol Laryngol 1978; 87(4 Pt 1):484–490. [PUBMED], [INFOTRIEVE], [CSA]
- King M, Angus G E. Effect of aerosolized bronchodilators on viscoelastic properties of canine tracheal mucus.Chest 1981; 80(6 suppl):852–854. [PUBMED], [INFOTRIEVE], [CSA]
- Kishioka C, Cheng P W, Seftor R E, Lartey P A, Rubin B K. Regulation of mucin secretion in the ferret trachea.Otolaryngol Head Neck Surg 1997; 117(5):480–486. [PUBMED], [INFOTRIEVE], [CSA]
- Tamaoki J, Chiyotani A, Tagaya E, Sakai N, Konno K. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.Thorax 1994; 49(6):545–548. [PUBMED], [INFOTRIEVE], [CSA]
- Ghafouri M A, Patil K D, Kass I. Sputum changes associated with the use of ipratropium bromide.Chest 1984; 86(3):387–393. [PUBMED], [INFOTRIEVE], [CSA]
- Hvizdos K M, Goa K L. Tiotropium bromide.Drugs 2002; 62(8):1195–1203. [PUBMED], [INFOTRIEVE], [CSA]
- Davis B, Roberts A M, Coleridge H M, Coleridge J C. Reflex tracheal gland secretion evoked by stimulation of bronchial C-fibers in dogs.J Appl Physiol 1982; 53(4):985–991. [PUBMED], [INFOTRIEVE], [CSA]
- Coles S J, Neill K H, Reid L M. Potent stimulation of glycoprotein secretion in canine trachea by substance P.J Appl Physiol 1984; 57(5):1323–1327. [PUBMED], [INFOTRIEVE], [CSA]
- De Sanctis G T, Rubin B K, Ramirez O, King M. Ferret tracheal mucus rheology, clearability and volume following administration of substance P or methacholine.Eur Respir J 1993; 6(1):76–82. [PUBMED], [INFOTRIEVE], [CSA]
- Jeffery P K. Anti-inflammatory drugs and experimental bronchitis.Eur J Respir Dis, Suppl 1986; 146:245–257. [CSA]
- Marom Z, Shelhamer J, Alling D, Kaliner M. The effects of corticosteroids on mucous glycoprotein secretion from human airways in vitro.Am Rev Respir Dis 1984; 129(1):62–65. [PUBMED], [INFOTRIEVE], [CSA]
- Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.Am Rev Respir Dis 1992; 145(3):548–552. [PUBMED], [INFOTRIEVE], [CSA]
- Goswami S K, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro.Am Rev Respir Dis 1990; 141(1):72–78. [PUBMED], [INFOTRIEVE], [CSA]
- Tamaoki J, Takeyama K, Tagaya E, Konno K. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.Antimicrob Agents Chemother 1995; 39(8):1688–1690. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K, Druce H, Ramirez O E, Palmer R. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis.Am J Respir Crit Care Med 1997; 155(6):2018–2023. [PUBMED], [INFOTRIEVE], [CSA]
- Koh Y Y, Lee M H, Sun Y H, Sung K W, Chae J H. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study [see comments].Eur Respir J 1997; 10(5):994–999. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tamaoki J, Takeyama K, Yamawaki I, Kondo M, Konno K. Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides.Am J Physiol 1997; 272(1 Pt 1):L15–L19. [PUBMED], [INFOTRIEVE], [CSA]
- Rubin B K, Henke M O, Dalhoff A. Anti-inflammatory properties of antibiotics other than macrolides. In: Rubin B K, Tamaoki J, eds. Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. BaselSwitzerland: Birkhaeuser Verlag, 2004:247–267.
- Campbell A H, O'Connell J M, Wilson F. The effect of chest physiotherapy upon the FEV1 in chronic bronchitis.Med J Aust 1975; 1(2):33–35. [PUBMED], [INFOTRIEVE], [CSA]
- May D B, Munt P W. Physiologic effects of chest percussion and postural drainage in patients with stable chronic bronchitis.Chest 1979; 75(1):29–32. [PUBMED], [INFOTRIEVE], [CSA]
- Oldenburg F A Jr, Dolovich M B, Montgomery J M, Newhouse M T. Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis.Am Rev Respir Dis 1979; 120(4):739–745. [PUBMED], [INFOTRIEVE], [CSA]
- Wollmer P, Ursing K, Midgren B, Eriksson L. Inefficiency of chest percussion in the physical therapy of chronic bronchitis.Eur J Respir Dis 1985; 66(4):233–239. [PUBMED], [INFOTRIEVE], [CSA]
- van der Schans C P. Airway clearance: assessment of techniques.Paediatr Respir Rev 2002; 3(2):110–114. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Main E, Prasad A, van der Schans C P. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.Cochrane Database Syst Rev 2005, DOI: 10.1002/14651858.CD002011.pub2.(1). [CSA]
- van der Schans C P, Postma D S, Koeter G H, Rubin B K. Physiotherapy and bronchial mucus transport.Eur Respir J 1999; 13(6):1477–1486. [PUBMED], [INFOTRIEVE], [CSA]
- Kim C S, Rodriguez C R, Eldridge M A, Sackner M A. Criteria for mucus transport in the airways by two-phase gas-liquid flow mechanism.J Appl Physiol 1986; 60(3):901–907. [PUBMED], [INFOTRIEVE], [CSA]
- Bennett W D, Foster W M, Chapman W F. Cough-enhanced mucus clearance in the normal lung.J Appl Physiol 1990; 69(5):1670–1675. [PUBMED], [INFOTRIEVE], [CSA]
- van der Schans C P, Piers D A, Postma D S. Effect of manual percussion on tracheobronchial clearance in patients with chronic airflow obstruction and excessive tracheobronchial secretion.Thorax 1986; 41(6):448–452. [PUBMED], [INFOTRIEVE], [CSA]
- van Hengstum M, Festen J, Beurskens C, Hankel M, Beekman F, Corstens F. Conventional physiotherapy and forced expiration manoeuvres have similar effects on tracheobronchial clearance.Eur Respir J 1988; 1(8):758–761. [PUBMED], [INFOTRIEVE], [CSA]
- van der Schans C P, Piers D A, Beekhuis H, Koeter G H, van der Mark T W, Postma D S. Effect of forced expirations on mucus clearance in patients with chronic airflow obstruction: effect of lung recoil pressure.Thorax 1990; 45(8):623–627. [PUBMED], [INFOTRIEVE], [CSA]
- Wong J W, Keens T G, Wannamaker E M, Crozier D N, Levison H, Aspin N. Effects of gravity on tracheal mucus transport rates in normal subjects and in patients with cystic fibrosis.Pediatrics 1977; 60(2):146–152. [PUBMED], [INFOTRIEVE], [CSA]
- Vandenplas Y, Diericx A, Blecker U, Lanciers S, Deneyer M. Esophageal pH monitoring data during chest physiotherapy.J Pediatr Gastroenterol Nutr 1991; 13(1):23–26. [PUBMED], [INFOTRIEVE], [CSA]
- van Hengstum M, Festen J, Beurskens C, Hankel M, van den B W, Corstens F. No effect of oral high frequency oscillation combined with forced expiration manoeuvres on tracheobronchial clearance in chronic bronchitis.Eur Respir J 1990; 3(1):14–18. [PUBMED], [INFOTRIEVE], [CSA]
- Hansen L G, Warwick W J. High-frequency chest compression system to aid in clearance of mucus from the lung.Biomed Instrum Technol 1990; 24(4):289–294. [PUBMED], [INFOTRIEVE], [CSA]
- Warwick W J, Hansen L G. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis.Pediatr Pulmonol 1991; 11(3):265–271. [PUBMED], [INFOTRIEVE], [CSA]
- Freitag L, Long W M, Kim C S, Wanner A. Removal of excessive bronchial secretions by asymmetric high-frequency oscillations.J Appl Physiol 1989; 67(2):614–619. [PUBMED], [INFOTRIEVE], [CSA]
- Sutton P P, Parker R A, Webber B A, Newman S P, Garland N, Lopez-Vidriero M T, Pavia D, Clarke S W. Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy.Eur J Respir Dis 1983; 64(1):62–68. [PUBMED], [INFOTRIEVE], [CSA]
- Lindemann H. The value of physical therapy with VRP 1-Desitin (“Flutter”).Pneumologie 1992; 46(12):626–630. [PUBMED], [INFOTRIEVE], [CSA]
- Thompson C S, Harrison S, Ashley J, Day K, Smith D L. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis.Thorax 2002; 57(5):446–448. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wolkove N, Kamel H, Rotaple M, Baltzan M A Jr. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD.Chest 2002; 121(3):702–707. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Konstan M W, Stern R C, Doershuk C F. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.J Pediatr 1994; 124(5 Pt 1):689–693. [PUBMED], [INFOTRIEVE], [CSA]
- Hofmeyr J L, Webber B A, Hodson M E. Evaluation of positive expiratory pressure as an adjunct to chest physiotherapy in the treatment of cystic fibrosis.Thorax 1986; 41(12):951–954. [PUBMED], [INFOTRIEVE], [CSA]
- Christensen H R, Simonsen K, Lange P, Clementsen P, Kampmann J P, Viskum K, Heideby J, Koch U. PEEP-masks in patients with severe obstructive pulmonary disease: a negative report.Eur Respir J 1990; 3(3):267–272. [PUBMED], [INFOTRIEVE], [CSA]
- Falk M, Kelstrup M, Andersen J B, Kinoshita T, Falk P, Stovring S, Gothgen I. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis.Eur J Respir Dis 1984; 65(6):423–432. [PUBMED], [INFOTRIEVE], [CSA]
- Christensen E F, Nedergaard T, Dahl R. Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy.Chest 1990; 97(3):645–650. [PUBMED], [INFOTRIEVE], [CSA]
- McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.Chest 1996; 110(4):889–895. [PUBMED], [INFOTRIEVE], [CSA]
- Peters K D, Kochanek K D, Murphy S L. Deaths: final data for 1996.Natl Vital Stat Rep 1998; 47(9):1–100. [PUBMED], [INFOTRIEVE], [CSA]
- Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000.MMWR, Surveill Summ 2002; 51(6):1–16. [CSA]
- Connors A F Jr, Dawson N V, Thomas C, Harrell F E Jr, Desbiens N, Fulkerson W J, Kussin P, Bellamy P, Goldman L, Knaus W A. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments).Am J Respir Crit Care Med 1996; 154(4 Pt 1):959–967. [PUBMED], [INFOTRIEVE], [CSA]
- Seneff M G, Wagner D P, Wagner R P, Zimmerman J E, Knaus W A. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.JAMA 1995; 274(23):1852–1857. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fuso L, Incalzi R A, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease.Am J Med 1995; 98(3):272–277. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Emerman C L, Effron D, Lukens T W. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD.Chest 1991; 99(3):595–599. [PUBMED], [INFOTRIEVE], [CSA]
- Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu J L. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.Respiration 2000; 67(5):495–501. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?Eur Respir J, Suppl 2002; 36:9s–19s. [CSA], [CROSSREF]
- Ball P, Harris J M, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis.QJM 1995; 88(1):61–68. [PUBMED], [INFOTRIEVE], [CSA]
- Adams S G, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD.Chest 2000; 117(5):1345–1352. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilson R, Schentag J J, Ball P, Mandell L. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.Clin Ther 2002; 24(4):639–652. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chodosh S, Schreurs A, Siami G, Barkman H W Jr, Anzueto A, Shan M, Moesker H, Stack T, Kowalsky S. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.Clin Infect Dis 1998; 27(4):730–738. [PUBMED], [INFOTRIEVE], [CSA]
- Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.Clin Infect Dis 1998; 27(4):722–729. [PUBMED], [INFOTRIEVE], [CSA]
- Anzueto A, Rizzo J A, Grossman R F. The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.Clin Infect Dis 1999; 28(6):1344–1345. [PUBMED], [INFOTRIEVE], [CSA]
- White A J, Gompertz S, Stockley R A. Chronic obstructive pulmonary disease. 6: the aetiology of exacerbations of chronic obstructive pulmonary disease.Thorax 2003; 58(1):73–80. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stockley R A, O'Brien C, Pye A, Hill S L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.Chest 2000; 117(6):1638–1645. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bhowmik A, Seemungal T A, Sapsford R J, Wedzicha J A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.Thorax 2000; 55(2):114–120. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wedzicha J A, Seemungal T A, MacCallum P K, Paul E A, Donaldson G C, Bhowmik A, Jeffries D J, Meade T W. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.Thromb Haemost 2000; 84(2):210–215. [PUBMED], [INFOTRIEVE], [CSA]
- Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald G A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.Am J Respir Crit Care Med 1998; 158(6):1709–1714. [PUBMED], [INFOTRIEVE], [CSA]
- Dev D, Wallace E, Sankaran R, Cunniffe J, Govan J R, Wathen C G, Emmanuel F X. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease.Respir Med 1998; 92(4):664–667. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fiorini G, Crespi S, Rinaldi M, Oberti E, Vigorelli R, Palmieri G. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction.Biomed Pharmacother 2000; 54(5):274–278. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Saetta M, Stefano DiA, Maestrelli P, Turato G, Ruggieri M P, Roggeri A, Calcagni P, Mapp C E, Ciaccia A, Fabbri L M. Airway eosinophilia in chronic bronchitis during exacerbations.Am J Respir Crit Care Med 1994; 150(6 Pt 1):1646–1652. [PUBMED], [INFOTRIEVE], [CSA]
- Zhu J, Qiu Y S, Majumdar S, Gamble E, Matin D, Turato G, Fabbri L M, Barnes N, Saetta M, Jeffery P K. Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.Am J Respir Crit Care Med 2001; 164(1):109–116. [PUBMED], [INFOTRIEVE], [CSA]
- Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas N M. Induced sputum CD8 + T-lymphocyte subpopulations in chronic obstructive pulmonary disease.Respir Med 2004; 98(1):57–65. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Selby C, Drost E, Lannan S, Wraith P K, MacNee W. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease.Am Rev Respir Dis 1991; 143(6):1359–1364. [PUBMED], [INFOTRIEVE], [CSA]
- Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, Ghio R, Ghio R, Fabiano F. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis.Eur Respir J 1997; 10(4):846–850. [PUBMED], [INFOTRIEVE], [CSA]
- Bhowmik A, Seemungal T A, Sapsford R J, Devalia J L, Wedzicha J A. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.Thorax 1998; 53(11):953–956. [PUBMED], [INFOTRIEVE], [CSA]
- Beeh K M, Beier J, Kornmann O, Mander A, Buhl R. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD.Chest 2003; 123(3):778–783. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gompertz S, O'Brien C, Bayley D L, Hill S L, Stockley R A. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.Eur Respir J 2001; 17(6):1112–1119. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]